Choroid plexus calcification: Clinical, neuroimaging and histopathological correlations in schizophrenia

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 2, 2013, Pages 365-369

  Marinescu, Ileana ^a   Udristoiu I ^a   Marinescu, D ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Blood brain barrier dysfunction; Cognitive dysfunction; Small vessel disease

Indexed keywords

ADULT; ARTICLE; ATROPHY; BLOOD BRAIN BARRIER; CALCINOSIS; CHOROID PLEXUS; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROIMAGING; PATHOLOGY; RADIOGRAPHY; SCHIZOPHRENIA; YOUNG ADULT;

ADULT; ATROPHY; BLOOD-BRAIN BARRIER; CALCINOSIS; CHOROID PLEXUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROIMAGING; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84879130399     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Přikrylová Vranová H, Mareš J, Nevrlý M, Stejskal D, Zapletalová J, Hluštík P, Kaňovský P, CSF markers of neurodegeneration in Parkinson's disease, J Neural Transm, 2010, 117(10):1177-1181.
2. McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M, Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology, 2013, 80(2):132-138.
3. Weinberger DR, The pathogenesis of schizophrenia: a neurodevelopmental theory. In: Nasrallah RA, Weinberger DR (eds), The handbook of schizophrenia. Vol. 1: The neurology of schizophrenia, Elsevier Science, Amsterdam, 1986, 387-405.
4. Murray RM, Lewis SW, Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed), 1987, 295(6600):681-682.
5. Fatemi SH, Folsom TD, The neurodevelopmental hypothesis of schizophrenia, revisited, Schizophr Bull, 2009, 35(3):528-548.
6. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M, Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms, Biol Psychiatry, 1999, 46(7):908-920.
7. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ, Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study, Arch Gen Psychiatry, 1998, 55(5):433-440.
8. Marinescu D, Mogoanta L, Udristoiu T, P03-161: The compared effect of zyprasidone and haloperidol at hippocampal and frontal cortex at rats, 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract Book, Eur Psychiatry, 2009, 24(Suppl 1):S1160.
9. Jefferys JGR, Hippocampal sclerosis and temporal lobe epilepsy: cause or consequence? Brain, 1999, 122(Pt 6): 1007-1008.
10. Johns P, Thom M, Epilepsy and hippocampal sclerosis: cause or effect? ACNR, 2008, 8(5):16-18.
11. Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, Stöcklein V, Bazarian JJ, Validation of serum markers for blood-brain barrier disruption in traumatic brain injury, J Neurotrauma, 2009, 26(9):1497-1507.
12. Chalbot S, Zetterberg H, Blennow K, Fladby T, Grundke- Iqbal I, Iqbal K, Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability, Neurosci Lett, 2010, 478(3):179-183.
13. Yarlagadda A, Kaushik S, Clayton AH, Blood brain barrier: the role of calcium homeostasis, Psychiatry (Edgmont), 2007, 4(12):55-59.
14. Steffens DC, Taylor WD, Krishnan KR, Progression of subcortical ischemic disease from vascular depression to vascular dementia, Am J Psychiatry, 2003, 160(10):1751-1756.
15. Townsend JB, Ziedonis DM, Bryan RM, Brennan RW, Page RB, Choroid plexus blood flow: evidence for dopaminergic influence, Brain Res, 1984, 290(1):165-169.
16. Insel BJ, Schaefer CA, McKeague IW, Susser ES, Brown AS, Maternal iron deficiency and the risk of schizophrenia in offspring, Arch Gen Psychiatry, 2008, 65(10):1136-1144.
17. Bombin I, Arango C, Buchanan RW, Significance and meaning of neurological signs in schizophrenia: two decades later, Schizophr Bull, 2005, 31(4):962-977.
18. Marchi N, Tierney W, Alexopoulos AV, Puvenna V, Granata T, Janigro D, The etiological role of blood-brain barrier dysfunction in seizure disorders, Cardiovasc Psychiatry Neurol, 2011, 2011:482415.
19. Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg MR, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D, Peripheral markers of brain damage and bloodbrain barrier dysfunction, Restor Neurol Neurosci, 2003, 21(3-4): 109-121.
20. Zito K, Scheuss V, NMDA receptor function and physiological modulation. In: Squire LR (ed), Encyclopedia of neuroscience, vol. 6, Elsevier Ltd., 2009, 1157-1164.
21. Javitt DC, Zukin SR, Recent advances in the phencyclidine model of schizophrenia, Am J Psychiatry, 1991, 148(10):1301-1308.
22. Wible CG, Anderson J, Shenton ME, Kricun A, Hirayasu Y, Tanaka S, Levitt JJ, O'Donnell BF, Kikinis R, Jolesz FA, McCarley RW, Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study, Psychiatry Res, 2001, 108(2): 65-78.
23. Hirayasu Y, Shenton ME, Salisbury DF, Dickey CC, Fischer IA, Mazzoni P, Kisler T, Arakaki H, Kwon JS, Anderson JE, Yurgelun-Todd D, Tohen M, McCarley RW, Lower left temporal lobe MRI volumes in patients with firstepisode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects, Am J Psychiatry, 1998, 155(10):1384-1391.
24. Nestor PG, Shenton ME, McCarley RW, Haimson J, Smith RS, O'Donnell B, Kimble M, Kikinis R, Jolesz FA, Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia, Am J Psychiatry, 1993, 150(12):1849-1855.
25. Sim K, DeWitt I, Ditman T, Zalesak M, Greenhouse I, Goff D, Weiss AP, Heckers S, Hippocampal and parahippocampal volumes in schizophrenia: a structural MRI study, Schizophr Bull, 2006, 32(2):332-340.
26. Albert O, Ancellin N, Preisser L, Morel A, Corman B, Serotonin, bradykinin and endothelin signalling in a sheep choroid plexus cell line, Life Sci, 1999, 64(10):859-867.
27. Watson JA, Elliott AC, Brown PD, Serotonin elevates intracellular Ca2+ in rat choroid plexus epithelial cells by acting on 5-HT2C receptors, Cell Calcium, 1995, 17(2):120-128.